Investors
News
Contact

About us
Inhalers
- Inhalers
- ICOres
- ICOcap
- ICOpre
- ICOone
- ICOone Nasal
- Patents
Development services
Partner with us
- Partner with us
- Access our inhalers
Insights
- Replacing injections with inhalation
- Boost your business with an innovative inhaler partner
Investors
Search
Menu Menu

Iconovo at CPhI in Madrid

October 17, 2018/in News /by Eva Norell

Iconovo attended CPhI in Madrid last week which marked the start of our new collaboration with Stevanato Group and ICOcap. Truly an exiting moment and a great success. Thanks to the team at Stevanato Group for an excellent show.

Share this entry

Share on Twitter
Share on LinkedIn
Share by Mail

https://www.iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png 0 0 Eva Norell https://www.iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png Eva Norell2018-10-17 14:14:242018-10-17 14:14:24Iconovo at CPhI in Madrid

Possessing a unique combination

of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.

ICONOVO AB

VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B

POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden

CONTACT

Phone: +46 46 275 67 77

VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se

CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se

SITEMAP

Home
Development services
Investors

Press releases

ICONOVO SIGNS AGREEMENT FOR DEVELOPMENT OF VACCINE AGAINST TUBERCULOSIS Iconovo develops new formulations to strengthen the product portfolio (only...

Scroll to top